Introduction
============

The acute muscle injuries, including crush, contusion, laceration or freezing are common. They are classified on the basis of inflammatory process in the early stage. On the one hand, infiltration of inflammatory cells following muscle injury promotes regeneration by clearing debris, engulfment and digestion of necrotic cell bodies. The other hand, inflammatory cells can produce growth factors and cytokines involved in the muscle regeneration process [@B1]. Inflammation of injured muscle has been interpreted as indicating an early stage of muscle regeneration because of the ability of neutrophils and macrophages accumulated at the site of damage to release soluble molecules, which are capable of affecting the transcriptional activity and the viability of regenerating muscle cells. However, excessive and prolonged inflammatory response can delay the regeneration, damage the normal muscle fibers, and even lead to muscle fibrosis, or chronic myoinjury [@B2]. It would be important to be able to attenuate the inflammatory response and decrease inflammatory cells infiltration reasonably in order to coordinate between inflammatory and regeneration process, resulting in better muscle functional recovery after myoinjury.

Nitric oxide (NO), the smallest signaling molecule known, synthesized from L-arginine by NO synthase (NOS) enzymes and plays an important role in skeletal muscle regeneration after injury [@B3]. In addition, NO is the characteristic key molecule that have been linked to the mechanical-stretch signal pathway of skeletal muscle [@B4]. Neuronal NOS (nNOS) and the endothelial NOS (eNOS) isoforms are constitutively expressed under non-pathological skeletal muscle. Inducialbe NOS (iNOS) is expressed in skeletal muscle primarily under severe inflammatory conditions, such as in the course of autoimmune inflammatory myopathies and acute myoinjury (e.g. crush injury and cardiotoxin injection) [@B5], [@B6], [@B7]. NO has been shown to enhance repair of the damaged muscle via actions on survival, activation and differentiation of myogenic precursor cell, via different signalling pathways [@B8]. NO action in muscle inflammation has been investigated and found to be multifaceted. For example, Hickey et al. showed that, in iNOS-deficient mice inflammatory cell infiltration of the skeletal muscle appears to be reduced [@B9]. However, McCafferty et al. [@B10] and Rigamonti et al. [@B7] supported iNOS-derived NO contribute to the protective response to injury by reducing the extent of leukocyte infiltration and by establishing an effective homeostatic inflammatory response of the skeletal muscle upon damage. The report from the team of Rovere-Querini P suggested that, expression levels of chemokines in iNOS-deficient muscles significantly higher than their wild type counterparts and display more infiltrating neutrophils after injury and a persistence of macrophages at later time points [@B11]. Recently we induced the proliferation of C2C12 myoblasts through the *in vitro* mechanical-stretch and detected the increased expression of NOS proteins. Our further work indicates that NO donor SNP reduced the levels of TLR3 and of proteins known to represent potential autoantigens [@B12]. Collectively, these findings show that the beneficial role of NO in muscle inflammation and repair processes after injury. However, the more detailed and definite data are necessary to clarify the effects of NO, which greatly increased its level in local muscle upon damage, on inflammatory process after myoinjury.

In this study, we explored the role of NO during inflammation process in Notexin model of skeletal muscle injury using an NO synthase inhibitor (nitro-L-arginine methylester: L-NAME) and an NO donor (sodium nitroprusside: SNP). Multiple inflammatory parameters, including mononuclear cell infiltration and apoptosis, the expression of muscle-autoantigens and TLRs, cytokines and chemokines associated with the preferential muscle tissue infiltration by inflammatory cells, were explored on day 4 and 7 post-injury. We observed the reduced monocytes/macrophages infiltration, and the increase number of apoptotic cells in the damaged muscle treated with SNP comparing to untreatment. As well, SNP treatment down-regulated mRNA and protein levels of autoantigens and TLR3, and mRNA levels of TNF-α, IL-6, MCP-1, MCP-3, and MIP-1α in damaged muscle. On the contrary, L-NAME induced more severe intramuscular infiltration of inflammatory cells, and mRNA level elevation of the above inflammatory mediators. Notably, we observed an increased number of MHC-I (H2-K^b^) positive new myofibers, and of the infiltrated CD8^+^ T cells in damaged muscle at the day 7 after L-NAME treatment. Taken together, these results support a beneficial role of NO in skeletal muscle repair through the down-regulation of muscle inflammatory responses.

Materials and Methods
=====================

Animals and experimental groups
-------------------------------

In all experiments, 6-to 8-wk-old female wild mice (C57BL/6) were used. The animals were randomly divided into four groups: (a) Control, (b) Notexin, (c) L-NAME (Notexin+L-NAME) and (d) SNP (Notexin+SNP). Animals were anesthetized and subsequently injected with 10ul of Notexin (25μg/ml in 0.9% NaCl; Latoxan, Rosans, France) into tibialis anterior (TA) muscles except for the first group. Mice were sacrificed at day 4 and 7 after Notexin injection. Animals of the L-NAME and SNP groups respectively received a 100 mg/kg dose of L-NAME (Santa Cruz, USA) or a 0.5 mg/kg dose of SNP (Sigma, USA) i.p. one day after Notexin injection. For animals sacrificed at day 7, additional one dose of injection i.p. of L-NAME or SNP was performed on day 4 post-injury. All experiments were performed in accordance with the guidelines of the Animal Experimentation Ethics Committee of the Southern Medical University. Injured TA muscles were collected and snap frozen for NO levels, RNA and protein analyses. For histology, muscles were collected and directly frozen in liquid nitrogen-cool isopentane.

Measurement of NO levels of muscle tissue
-----------------------------------------

The muscle samples were collected as described above and tissue homogenates were made. After centrifugation, the supernatant of muscle tissue homogenate were used for next treatment. Protein concentrations were evaluated using a BCA assay kit (KeyGEN, China). The total concentration of nitrate and nitrite in the muscle supernatant were determined by Nitric Oxide Metabolite Detection Kit (PanEra, China) and the absorbance of sample was measured at 550nm wavelength using Multiscan Go microplate reader (ThermoFisher, Finland). Finally, the NO concentration was calculated according to the manufacturer\'s instructions.

RNA extraction and quantitative real-time PCR analysis
------------------------------------------------------

Total RNA was extracted from muscle tissue using RNA extraction kit (DongSheng, China), following manufacturer\'s recommendations. Total RNA (1ug) was then used for reverse transcription (RT) with commercially available kit (Revert Aid First Strand cDNA Synthesis Kit, Fermentas). Real-time polymerase chain reaction (PCR) was performed in triplicate with an ABI Step One Plus system (Applied Biosystems, USA) and a fluorescence-labeled SYBR Green/ROX qPCR Master Mix kit (Fermentas) using specific primers. Muscle autoantigens (Mi-2, HARS, Ku-70, DNA-pkcs), eNOS, iNOS, nNOS,TLR3, TLR7, TNF-α, IL-1, IL-10, IL-6, TGF-β, MCP-1, MCP-3, MIP-1α and with glyceraldehyde-3-phosphate dehydrogenase (GAPDH) taken as an endogenous control (primer sequences and sizes of product are listed in table [1](#T1){ref-type="table"}) were detected. The results were analyzed with SOS2.1 software (Applied Biosystems). Expression of the genes was calculated from the accurate threshold cycle (Ct), which is the PCR cycle at which an increase in fluorescence from SYBR Green probes above the baseline signal can first be detected. The Ct values for GAPDH were compared with those from Mi-2, HARS, Ku-70, DNA-pkcs, eNOS, iNOS, nNOS, TLR3, TLR7, TNF-α, IL-10, IL-1, IL-6, TGF-β, MCP-1, MCP-3 and MIP-1α and in each well to calculate ΔCt. Data of the treated conditions were expressed relative to the signal obtained for the average of the untreated controls by the ΔΔCt calculation. The triplicate ΔΔCt values for each sample were averaged.

Western blot analysis
---------------------

Skeletal muscle protein extraction was performed according to the manufacturer\'s protocol (KeyGEN, China). Protein concentrations were evaluated using a BCA assay kit (KeyGEN, China). Equal amounts of proteins were electrophoresed on 6-12% SDS-polyacrylamide gel and transferred to Immobilon P membrane (Millipore, USA). Membranes were blocked in 5% non-fat dried milk in Tris-buffered saline/Tween-20 (TBS-T: 20mM Tris, pH7.5, 150 mM NaCl, 0.05% Tween-20) for 1h at RT. The following rabbit polyclonal or mouse monoclonal antibody were used for detection: Rabbit polyclonal anti-Mi-2 (1:2000, abcam, USA); Rabbit polyclonal anti-HARS (1:500, NOVUS, USA); Rabbit polyclonal anti-Ku-70 (1:800, NOVUS, USA); Rabbit polyclonal anti-DNA-PKcs (1:100, Santa Cruz, USA) ;Rabbit polyclonal anti-TLR3 (1:800, abcam, USA); Rabbit polyclonal anti-TLR7 (1:200, Santa Cruz, USA); mouse monoclonal anti-GAPDH (1:3000, KANGCHEN, China). Primary antibodies were incubated for 20h at 4℃ in 5% non-fat dried milk in TBS-T. The membrane was then washed three times in TBS-T and incubated for 1h at RT with horseradish peroxidase conjugated goat anti-rabbit IgG (1:4000, Fudebio, China) or goat anti-mouse IgG (1:2000, CST, USA), in 5% non-fat dried milk in TBS-T. After three washes in TBS-T, the protein bands were visualized by enhanced chemiluminescence (ECL) detection reagents (Applygen Technologic Inc., China). Immunoreactive bands was detected by the ECL detection system (Protein Simple, USA), and densitometric values were analyzed with Quantity One (Bio-Rad, USA). Relative expression of each immunoreactive band was calculated by comparison with GAPDH.

Histological and immunofluorescence detection
---------------------------------------------

Snap-frozen whole TA muscle was transversely cryosectioned (8μm), and either stained with hematoxylin and eosin or prepared for immunofluorescence. For immunofluorescence, muscle was fixed with cold acetone and incubated with rat anti-mouse F4/80 (1:200, eBioscience, USA); rat anti-mouse CD11b (1:200, eBioscience, USA); rat anti-mouse CD8α (1:200, eBioscience, USA); rat anti-mouse H-2K^b^ (1:100, BD, USA); rabbit polyclonal anti-caspase3 (1:500, abcam, USA);rabbit polyclonal anti-dystrophin (1:200, Santa Cruz, USA); or rabbit polyclonal anti-CD3ε (1:200, Abcam, USA). Rhodamine-conjugated goat anti-rat IgG (1:200, Santa Cruz, USA), FITC-conjugated goat anti-rabbit IgG (1:200, Santa Cruz, USA) or Alexa 568-conjugated rat anti-mouse IgG (1:1000, Invitrogen, USA) were used as secondary antibodies. Nuclei were counterstained with DAPI. Slides were viewed with an Olympus BX51 fluorescence microscope (Olympus, Japan). For results analysis, the Image J software was performed to quantify the intensity of staining. The integrated optical density (IOD) and area of interest (AOI) of all the positive staining (intense red staining) were measured, respectively. The mean density (IOD/AOI) was then calculated. Cell apoptosis was determined by counting the number of CD11b^+^caspase-3^+^ cells and expressed as a percentage of total CD11b^+^cells counted.

Statistical Analysis
--------------------

All data are expressed as mean ± standard deviation (SD). One-way ANOVA was used for multiple comparisons (Duncan\'s multiple range test) using SPSS ver.13.0 software. *P*values\<0.05 were considered as statistically significant.

Results
=======

SNP and L-NAME Treatment Regulates NO and NOS levels in Notexin-Damaged TA Muscle
---------------------------------------------------------------------------------

Using H&E and dystrophine fluorescence staining, we observed on day 4 post-injury, Notexin injection in TA muscle in WT mice induced myofiber necrosis and degeneration. Damage was gradually replaced by smaller regenerating myofibers, and centrally nucleated myofibers became prominent on day 7. Myorepair was almost completed on day 10 (Fig.[1](#F1){ref-type="fig"}). We therefore took day 4 and 7 as the detection time points of necrosis and regeneration, respectively. As expected, mean NO concentration (umol/g muscle protein) in damaged muscle tissue significantly increased to 21.98 and 11.36 after NO donor SNP injection, but decreased to 3.26 and 1.97 after L-NAME injection, compared to animals with Notexin-treatment alone (12.46 and 5.13 ) on day 4 and 7 post-injury, respectively (Fig.[2](#F2){ref-type="fig"}). Our qRT-PCR analysis further proved that, the mRNA expression of nNOS, eNOS and iNOS greatly increased in Notexin-damaged muscle at day 4 and 7, with the highest level of iNOS. L-NAME treatment caused the significant down-regulation of three NOS isoforms in damaged muscle, compared to untreated but damaged ones (Fig.[3](#F3){ref-type="fig"}).

Nitric Oxide Interfere with Muscle-Autoantigens and TLR3 Expression in Notexin-Damaged Skeletal Muscle tissue
-------------------------------------------------------------------------------------------------------------

Using an *in vitro* culturing system of C2C12 myoblasts, we recently found the expression of TLR3 and of proteins known to represent autoantigens in inflammatory autoimmune myopathies were down-regulated by SNP and, conversely, up-regulated by L-NAME [@B12]. This data suggested a role of NO on help to control skeletal muscle inflammation and immune response. For further investigating the*in vivo* effect of NO on myoinjury induced inflammation response, in this study, Notexin-induced mice myoinjuy model were prepared and treated with SNP, or L-NAME respectively. The expression levels of muscle autoantigens (Mi-2, HRS, DNA-PKcs and Ku-70) and the proinflammatory TLR3 and TLR7 were analyzed in damaged muscle tissue by qRT-PCR and immunoblotting.

Although DNA-PKcs and TLR7 expression has no change (data not shown), we found most of autoantigens and TLR3 up-regulated in damaged muscle compared to normal muscle. As shown in Figure [4](#F4){ref-type="fig"} and Figure [5](#F5){ref-type="fig"}, mRNA and protein levels of Mi-2, HRS, Ku-70 and TLR3 peaked around day 4 following Notexin injection, and gradually down-regulated as myofibers had begun to reform (day 7), but still higher than normal muscle. It\'s worth noting that the expression levels of Mi-2, HRS, Ku-70 and TLR3 in damaged muscle decreased significantly after SNP treating, but increased after L-NAME treating, compared to muscle with Notexin-damage alone, especially at the muscle degenerating period (day 4). Because autoantigens and TLR3 represent the important immune/inflammatory mediators in damaged muscle [@B13], [@B14], this data suggested the inhibition effects of NO on muscle inflammation.

Nitric Oxide Suppresses Notexin-Induced Intramuscular Infiltration of Monocytes/Macrophages
-------------------------------------------------------------------------------------------

Because muscle injury and healing encompass the recruitment of inflammatory cells, and the inflammatory response to acute muscle damage is an innate immune response [@B15], we next investigated whether SNP and L-NAME treatment interferes with the intramuscular infiltration of monocytes/macrophages after Notexin injection. We conducted immunostaining to assess the infiltration of CD11b^+^ and F4/80^+^ cells on damaged and intact muscles of B6 mice on day 4 and 7 post-injury. The extent of infiltration was evaluated by fluorescent staining intensity analysis. As shown in figure [6](#F6){ref-type="fig"}, SNP treatment caused a significant decrease of the number of CD11b^+^and F4/80^+^cells in damaged muscles. On day 4 and 7 post-injury, the mean value of fluorescence intensity (Rhodamine) of infiltrated monocytes/macrophages reduced to 180 and 131 for CD11b, 184 and 147 for F4/80 respectively, comparing to that of Notexin damage alone at the same detecting time point (213 and 176 for CD11b, 217 and 167 for F4/80, respectively). Nevertheless, a powerful increase in the number of CD11b^+^and F4/80^+^cells was detected in damaged muscle tissue of B6 mice with L-NAME treatment (the mean value of fluorescence intensity of infiltration in muscle elevated to 243 and 266 for CD11b, and 249 and 217 for F4/80 at day 4 and 7, respectively), comparing to muscle damaged alone. Indeed, at the later regenerating time point (10d, myorepair was almost complete at this stage), persistent necrotic fiber segments contained massive inflammatory cell infiltration was still observed in muscle tissue of mice treated with L-NAME (data not shown).

Because NO is one of modulators of apoptosis of inflammatory cells [@B16], we next examined whether SNP treatment induce apoptosis of myeloid cells infiltrated in damaged muscle. Using immunofluorecence staining and cell counting, we found SNP injection induced more severe inflammatory cells apoptosis in damaged muscle: CD11b^+^caspase-3^+^ cells were about 55.6%, and 76.4% of the total of CD11b^+^ cells, on the day 4 and 7 post-injury, respectively. However, double staining cells increased to 84.5%, and 82.5% respectively after SNP treating (Fig.[7](#F7){ref-type="fig"}). These data suggest that NO acts as an anti-inflammatory role by blocking the intramuscular infiltration, and by inducing the apoptosis of innate leukocytes.

Nitric Oxide Inhibits the Production of Pro-inflammatory Cytokines and Chemokines in the Notexin-Injuried Muscle
----------------------------------------------------------------------------------------------------------------

Monocytes and macrophages dominate a basic inflammatory response to muscle damage, which are a rich source of diverse cytokines and chemokines at the site of inflammation [@B17]. To evaluate more directly how the muscle inflammation response is affected by NO molecule, we next analyzed the expression of selected pro-inflammatory cytokines involving TNF-α, IL-1 and IL-6; anti-inflammatory cytokines involving TGF-β and IL-10, and the macrophage-sourced chemokines involving MIP-1α, MCP-1 and MCP-3, which have been associated with the preferential biological role during the muscle damage-induced inflammation response. In agreement with previous reports [@B15], our qPCR analysis demonstrated the up-regulation of mRNA level of TGF-β (on day 4 and 7) and IL-10 (on day 4) in TA muscle after myoinjury. However, we did not find SNP and L-NAME treatment effected on mRNA levels of TGF-β and IL-10 in Notexin-injected TA muscle (data not shown).

Noteworthy, SNP treatment resulted in a significant down-regulation of mRNA levels of pro-inflammatory TNF-α and IL-6 in damaged muscle, compared to that of muscle damaged alone, and this inhibition tendency maintained during the muscle necrosis (day 4) and repair processes (day 7) (Fig. [8](#F8){ref-type="fig"}A). In contrast, L-NAME stimulated a conspicuous production of TNF-α and IL-6, as mRNA levels of them in damaged TA muscle of mice treating with L-NAME were nearly the double of that damaged alone (Fig. [8](#F8){ref-type="fig"}A).

Similarly to what was observed above, we noticed that, after changing NO level *in vivo* artificially, the expression of macrophage-sourced chemokines in TA muscle was changed on day 4 and 7 post-injury: SNP treatment effectively diminished mRNA levels of MIP-1α, MCP-1, and MCP-3 (Fig. [8](#F8){ref-type="fig"}B). Conversely, L-NAME treatment resulted in a striking increase in the production of these genes (Fig. [8](#F8){ref-type="fig"}B). Taken together, these results collectively confirm that NO is crucial for the negative regulation of pro-inflammatory cytokines and chemokines production in damaged muscle tissue.

Nitric Oxide Interfere with Intramuscular Infiltration of CD8^+^ T cell and MHC-I Expression on New Myofibers after Myoinjury
-----------------------------------------------------------------------------------------------------------------------------

Muscle antigens have been shown to induce migration of T lymphocytes to the endomysium or perimysium after myoinjury [@B13], [@B14], [@B18]-[@B20], and MHC-I gene expression on regenerated myofibers is a possible reason of intramuscular CD8^+^ T cells infiltration [@B21], [@B22]. We have found NO concentration change by SNP or L-NAME injection i.p. influences on mRNA and protein expression of muscle autoantigens and TLR3 in Notexin-damaged TA muscle. We next wish to find out whether NO is involved in the myofiber MHC-I expression and intramuscular CD8^+^ T cell infiltration.

We conducted double immunostaining to assess the presence of CD3ε^+^CD8α^+^ T cells, and MHC-I molecule H-2K^b^-expressing myofibers on Notexin-damaged muscle of B6 mice with or without SNP and L-NAME treatment on day 4 and 7. Sarcolemmal H-2K^b^ expression was assessed by comparison to basement membrane staining with dystrophine. As shown in figure [9](#F9){ref-type="fig"}, the number of CD3ε^+^CD8α^+^ T cells and H-2K^b+^ myofiber were rather less in Notexin-injuried TA muscle (0-2/per slide), and only observed on day 7 post-injury. Interestingly, L-NAME treatment resulted in an increased number of H-2K^b^ positive myofibers (3-7/per slide), and of the infiltrated CD3ε^+^CD8α^+^ T cells in damaged muscle on day 7 post-injury. However, we did not found the effects of SNP treatment on the number of CD8^+^T cell and H-2K^b+^myofibers in damaged TA muscle (data not shown). All together, these results suggest the inhibition effects of NO on CD8^+^ T cell intramuscular infiltration.

Discussion
==========

It has long been recognized that inflammatory processes are essential in skeletal muscle injury and repair. New findings confirmed that this processes not wholly beneficial for muscle regeneration. For example, the invading mononuclear cells can product proinflammatory cytokines, and release cytolytic and cytotoxic molecules, such as superoxide or its conversion hydrogen peroxide, which can lyse the cell membranes and damage the muscle even further. Persistence of inflammatory cells leads to damage of the surrounding normal tissue and exacerbation of inflammation, even lead to secondary injury [@B23]. It would be helpful to coordinate between inflammatory and regeneration process, resulting in better muscle functional recovery after myoinjury. Nitric Oxide-dependent satellite cell activation and myofiber regeneration during acute and chronic myoinjuries have been extensively studied [@B8], [@B24]. However, there are still few published studies investigating the role of NO in post-injury muscle inflammation response. Until now, the role of NO in muscle inflammation remains controversial [@B25]. Some scholars believed that NO is an anti-inflammatory molecule [@B7], [@B10], [@B11] and our previous *in vitro* experiments also support the view [@B12]. In this study, we examined whether and how NO participate in the mediation of muscle inflammatory response using the mice model of Notexin induced myoinjury.

Since the concomitant up-regulation of TLRs or of potential muscle autoantigens could potentially aggravate muscle inflammation and damage in immune-mediated muscle disease by stimulating cytokines and chemokines production, as well as the activation of autoimmune T cells [@B13], [@B14], in this study, we firstly explored whether the blocking of NO production by L-NAME, or the increasing of NO output by SNP during the myoinjury phases may influence on the expression of muscle autoantigens and TLRs. In our work, autoantigens and TLR-3 were detected to up-regulate persistently from day 4 to day 7 post-injury, which supports the opinion that Notexin induced a rapid muscle necrosis and sequentially reformation of new myofibers, and those new immature muscle cells preferentially express autoantigens and TLR3 during the conditions of muscle inflammation [@B19]. Previous studies have shown that NO promotes myogenic precursor cell activation, regeneration and fusion in acutely and chronically damaged muscles [@B8], [@B24]. It seems that we can reasonably presume that the increase of NO concentration in damaged muscle should contribute to up-regulate autoantigens and TLR3 expression, by promoting new myofiber formation. Unexpectedly, we found mRNAs and protein levels of Mi-2, HRS, Ku-70 and TLR3 in Notexin-damaged skeletal muscle were significantly down-regulated by SNP treatment, but up-regulated by L-NAME treatment at the muscle necrosis and regeneration phages. This observation suggests NO can negatively regulate immune response by down-regulating autoantigens and pro-inflammatory TLR3 after myoinjury.

Several studies have confirmed that, during the muscle inflammatory phase there is a great increase in local NO production [@B26], [@B27]. Muscle-derived NO appears to be a particularly important regulator of muscle inflammation and damage by invading inflammatory cells [@B28]. McCafferty et al. demonstrated iNOS-derived NO regulate the inflammation response to injury by reducing the extent of leukocyte infiltration [@B10]. Our results support this opinion, because we observed SNP treatment decreased the number of infiltrated CD11b^+^ and F4/80^+^ cells in Notexin-damaged muscle tissue, but L-NAME resulted in a significant increase in cell infiltration. *In vitro* and *in vivo* studies have shown that muscle-derived NO reduces of inflammatory damage by increasing the apoptosis of infiltrated cells and inhibiting the expression of adhesion molecules, reduces neutrophil-mediated lysis of muscle cells and decreases superoxide concentration, forming less reactive intermediates [@B29]. Our results clearly show the capacity of NO donor SNP to induce apoptosis in intramuscular infiltrated mononuclear cells. By exploring the expression of selected pro- and anti-inflammatory cytokines, and the macrophage-sourced chemokines in Notexin-damaged muscle tissue with or without SNP or L-NAME treatment, we confirmed that SNP treatment resulted in a significant production inhibition of TNF-α, IL-6, MIP-1α, MCP-1, and MCP-3 in damaged muscle. In contrast, L-NAME stimulated a conspicuous production of those molecules. Therefore, it is conceivable that endogenous NO functions as a negative modulator of muscle inflammatory response.

One peculiar immunologic feature of myofibers is that they do not express detectable levels of major histocompatibility complex class I (MHC-I) molecules. In contrast, cultured myogenic precursors [@B30] and regenerating myofibers from myopathic muscle show surface reexpression of MHC-I [@B31]-[@B34]. Hence, surface MHC-I likely participates in the pathogenesis of myoinjury by its relationship with autoreactive cytotoxic CD8^+^ T cells. However, in acutely damaged skeletal muscle, intramuscular CD8^+^ T cell infiltration and MHC-I expression on regenerated myofibers is rather occasional, despite of heavy macrophage/monocyte infiltration. This reflects that normal muscle tissue is resistant to autoimmunity. Interesting, in patients and animal models of autoimmune myositis, nNOS is absent from the sarcolemma, and relocated to the cytosol, leading to a reduction of total muscle NOS activity [@B35], [@B36]. The restoration of NO generation by transgenic expression of nNOS ameliorates the dystrophic phenotype [@B37]. Whether muscle-derived NO participates in governing immune priming/tolerance toward muscle antigens are still poorly defined. From our data that NO interfere with muscle autoantigens and TLR3 expression, it is possible NO has a role on regulating muscle auto-tolerance. Using fluorescent staining to detect H-2K^b^ expression in damaged muscle of B6 mice treating with L-NAME, we observed an obviously increased number of H-2K^b^ positive myofibers, compared to that of Notexin-damaged muscle alone. In accord with this result, we found the increased number of CD3ε^+^CD8α^+^ T cells in damaged muscle on day 7 post-injury. We therefore assume that muscle-derived NO reduces of muscle damage through inhibiting the MHC-I expression on regenerated myofibers, and therefore blocking the infiltration of CD8^+^ T cell. However, further experimental studies are needed to verify this assumption.

Collectively the data presented here show that, NO, a multi-functional molecule, is an intrinsic negative regulator of muscle inflammatory response. Muscle-derived NO helps to reduce inflammatory damage of skeletal muscle through suppressing muscle-autoantigens and TLR3 expression, decreasing the infiltration of leukocytes, inducing the apoptosis of infiltrated cells, and down-regulating the production of pro-inflammatory cytokines and chemokines. Our founding also imply a possible inhibition effects of NO on MHC-I expression on new myofibers and intramuscular infiltration of CD8^+^ T cell after myoinjury.
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:   the catalytic subunit of DNA-dependent protein kinase
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![**Histopathologic features of Notexin-induced acute myoinjury of TA.** The top images: standard H&E staining for morphologic assessment. The bottom images: Dystrophin immunofluorescence staining (green). On day 0 (d0) (prior to myoinjury), the muscle appears normal. On day 4, full-blown necrosis and myophagocytosis are evident. On day 7, small regenerating myofibers with central nuclei neighbored by mononuclear inflammatory cells have appeared. On day 10, decreased inflammatory changes are seen in healing muscle. Bar = 50μm.](ijbsv11p0156g001){#F1}

![**SNP and L-NAME treatment influence on the total Nitric Oxide level in TA muscle**. Nitrate/Nitrite Assay was performed to evaluate the total NO concentration in TA muscle on day 4 and 7 post-injury. One-way ANOVA was used for multiple comparisons. All data are presented as mean ± SD (*n*=3). (\*\**p*\<0.01)](ijbsv11p0156g002){#F2}

![**L-NAME treatment interfere with mRNA levels of NOS isoforms in Notexin-damaged TA muscle.**mRNA levels of NOS isoforms were evaluated in 4d (A) and 7d (B) damaged muscle by qRT-PCR. One-way ANOVA was used for multiple comparisons. All data are presented as mean ± SD (*n*=3). (\*\**p*\<0.01, \*\*\**p*\<0.001).](ijbsv11p0156g003){#F3}

![**SNP and L-NAME treatment interfere with mRNA levels of muscle-autoantigens and TLR3 in Notexin-damaged TA muscle**. mRNA levels corresponding to proteins that can serve as muscle autoantigens and TLR3 were evaluated in 4d (A) and 7d (B) damaged muscle by qRT-PCR. One-way ANOVA was used for multiple comparisons. All data are presented as mean ± SD (*n*=3). (\**p*\<0.05, \*\**p*\<0.01).](ijbsv11p0156g004){#F4}

![**SNP and L-NAME treatment interfere with protein expression of muscle-autoantigens and TLR3 in Notexin-damaged TA muscle. Western blot analysis showing autoantigens and TLR3 expression in Notexin-damaged muscle on day 4 (A) and 7 (C).** The relative band intensities from western blots experiments were normalized to the level of GAPDH and analyzed with Quantity One software (B and D). One-way ANOVA was used for multiple comparisons. All data are presented as mean ± SD (*n*=3). (\**p*\<0.05, \*\**p*\<0.01).](ijbsv11p0156g005){#F5}

![**SNP and L-NAME treatment interfere with Notexin-induced intramuscular infiltration of monocytes/macrophages.** Representative immunofluorescence-stained muscle sections obtained at day 0 (A), 4 (B) and 7 (B). Quantification of the mean fluorescent intensity values of CD11b (C) and F4/80 (D) in muscle cross sections was shown. One-way ANOVA was used for multiple comparisons. All data are presented as mean ± SD (*n*=3). (\**p*\<0.05, \*\**p*\<0.01). Bar = 50μm.](ijbsv11p0156g006){#F6}

![**SNP treatment induce apoptosis of infiltrated cells in the Notexin-damaged TA muscle.**Representative caspase 3 and CD11b immunofluorescence-stained muscle sections obtained on day 4 and 7 (A). Caspase-3^+^CD11b^+^ cells increased after SNP treating, compared to that of myoinjury alone. Arrows indicate caspase-3^+^CD11b^+^ cells. Cell apoptosis was determined by counting the number of CD11b^+^caspase-3^+^ cells and expressed as a percentage of total CD11b^+^cells counted (B). One-way ANOVA was used for multiple comparisons. All data are presented as mean ± SD (*n*=3). (\**p*\<0.05, \*\**p*\<0.01). Bar = 100μm.](ijbsv11p0156g007){#F7}

![**SNP and L-NAME treatment interfere with the production of pro-inflammatory cytokines and chemokines in the Notexin-damaged TA muscle.** mRNA levels of TNF-α and IL-6 (A), MCP-1, MCP-3 and MIP-1α (B) were quantified by qRT-PCR. One-way ANOVA was used for multiple comparisons. All data are presented as mean ± SD (*n*=3). (\**p*\<0.05, \*\**p*\<0.01)](ijbsv11p0156g008){#F8}

![**L-NAME treatment interferes with intramuscular infiltration of CD8^+^ T cell and MHC-I expression on regenerated myofibers after myoinjury.**The number of CD3ε^+^CD8α^+^ T cells and of H-2K^b+^ myofiber increased after L-NAME treating, compared to that of myoinjury alone. Arrows indicate CD3ε^+^CD8α^+^ T cells, or H-2K^b^positive myofibers. Bar = 50μm.](ijbsv11p0156g009){#F9}

###### 

Primer sequences used for qRT-PCR

  Gene name   Forward(5\'→3\')        Reverse(5\'→3\')         product size
  ----------- ----------------------- ------------------------ --------------
  eNOS        GTTTGTCTGCGGCGATGT      GTGCGTATGCGGCTTGTC       192bp
  iNOS        GAGCGAGTTGTGGATTGTC     CCAGGAAGTAGGTGAGGG       133bp
  nNOS        ACAACCTCGCTACTATTCCA    CCTTCTCCATCTCGGGTA       102bp
  Mi-2        CCCGAGGAGTGTGGA ACTA    CCCTACCACCCTAGCCAAG      62bp
  HARS        GATGGGATGTTTGCTGTCTG    TCCCACCATCTCATTCTTCA     114bp
  Ku-70       GACAGCAGGAAGTGGAGACA    GCCACGAACAGAGTCTTGAA     91bp
  DNA-pkcs    ATATCCTTGGCAGGACTTGG    AGGTCCTCTCGGAGACAGAA     92bp
  TLR3        TCTGTTTGCGAAGAGGAATG    AATTCCGAGATCCAAGTGCT     114bp
  TLR7        TTGCAACTGTGATGCTGTGT    TTTGTGTGCTCCTGGACCTA     106bp
  TNF-α       GGCGGTGCCTATGTCTCA      CCTCCACTTGGTGGTTTGT      117bp
  IL-6        GGCAATTCTGATTGTATG      CTCTGGCTTTGTCTTTCT       208bp
  IL-1        GCCCATCCTCTGTGACTC      TGTGCCGTCTTTCATTAC       283 bp
  IL-10       TTTCAAACAAAGGACCAG      GGATCATTTCCGATAAGG       100bp
  TGF-β       GGCGGTGCTCGCTTTGTA      TCCCGAATGTCTGACGTATTGA   201bp
  MCP-1       GGGTCCAGACATACATTAA     ACGGGTCAACTTCACATT       119bp
  MCP-3       GCTTCTGTGCCTGCTGCTC     CTTCCATGCCCTTCTTTG       197bp
  MIP-1α      CTGCCCTTGCTGTTCTTC      CAAAGGCTGCTGGTTTCA       154bp
  GAPDH       CAATGTGTCCGTCGTGGATCT   GTCCTCAGTGTAGCCCAAGATG   124bp
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